Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014
Gastroenterología Diagnóstica Terapeútica · Casa Sollievo della Sofferenza · +10 more institutions
Abstract
This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). It addresses the prophylaxis of post-endoscopic retrograde cholangiopancreatography (post-ERCP) pancreatitis. Main recommendations 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or indomethacin immediately before or after ERCP in all patients without contraindication. In addition to this, in the case of high risk for post-ERCP pancreatitis (PEP), the placement of a 5-Fr prophylactic pancreatic stent should be strongly considered. Sublingually administered glyceryl trinitrate or 250 µg somatostatin given in bolus injection might be considered as an option in high risk cases if…
Citation impact
- FWCI
- 37.57
- Percentile
- 100%
- References
- 189
Authors
11- JDJean‐Marc DumonceauCorresponding
Gastroenterología Diagnóstica Terapeútica
- AAAngelo Andriulli
Casa Sollievo della Sofferenza, Istituti di Ricovero e Cura a Carattere Scientifico
- BJB. Joseph Elmunzer
Medical University of South Carolina
- AMAlberto Mariani
Vita-Salute San Raffaele University
- TMTobias Meister
HELIOS Albert-Schweitzer-Klinik Northeim
Topics & keywords
- Medicine
- Pancreatitis
- Pancreatic duct
- Guideline
- Contraindication
- Endoscopic retrograde cholangiopancreatography
- Stent
- Surgery
- Good health and well-being